WOLFGANG WINKELMAYER to Comorbidity
This is a "connection" page, showing publications WOLFGANG WINKELMAYER has written about Comorbidity.
Connection Strength
1.198
-
Sex differences in chronic kidney disease awareness among US adults, 1999 to 2018. PLoS One. 2020; 15(12):e0243431.
Score: 0.127
-
Cause of kidney disease and cardiovascular events in a national cohort of US patients with end-stage renal disease on dialysis: a retrospective analysis. Eur Heart J. 2019 03 14; 40(11):887-898.
Score: 0.112
-
Employment among Patients Starting Dialysis in the United States. Clin J Am Soc Nephrol. 2018 02 07; 13(2):265-273.
Score: 0.104
-
Associations of Glycemic Control With Cardiovascular Outcomes Among US Hemodialysis Patients With Diabetes Mellitus. J Am Heart Assoc. 2017 Jun 07; 6(6).
Score: 0.099
-
Statin use and hip fractures in U.S. kidney transplant recipients. BMC Nephrol. 2017 May 01; 18(1):145.
Score: 0.099
-
Correlates of poor glycemic control among patients with diabetes initiating hemodialysis for end-stage renal disease. BMC Nephrol. 2015 Dec 09; 16:204.
Score: 0.090
-
Patient characteristics and outcomes by GN subtype in ESRD. Clin J Am Soc Nephrol. 2015 Jul 07; 10(7):1170-8.
Score: 0.087
-
Longer-term outcomes of darbepoetin alfa versus epoetin alfa in patients with ESRD initiating hemodialysis: a quasi-experimental cohort study. Am J Kidney Dis. 2015 Jul; 66(1):106-13.
Score: 0.086
-
Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis. 2011 Sep; 58(3):409-17.
Score: 0.066
-
Underuse of ACE inhibitors and angiotensin II receptor blockers in elderly patients with diabetes. Am J Kidney Dis. 2005 Dec; 46(6):1080-7.
Score: 0.045
-
Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis. 2005 Aug; 46(2):225-32.
Score: 0.044
-
Determinants of delayed nephrologist referral in patients with chronic kidney disease. Am J Kidney Dis. 2001 Dec; 38(6):1178-84.
Score: 0.034
-
Use of QT Prolonging Medications by Hemodialysis Patients and Individuals Without End-Stage Kidney Disease. J Am Heart Assoc. 2020 07 07; 9(13):e015969.
Score: 0.031
-
Cause-Specific Mortality in Patients with Chronic Kidney Disease and Atrial Fibrillation. Am J Nephrol. 2018; 48(1):36-45.
Score: 0.027
-
Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving?Global Outcomes (KDIGO) Controversies?Conference. Kidney Int. 2018 03; 93(3):545-559.
Score: 0.026
-
Warfarin Initiation, Atrial Fibrillation, and Kidney Function:?Comparative Effectiveness and Safety of?Warfarin?in?Older?Adults?With Newly Diagnosed Atrial?Fibrillation. Am J Kidney Dis. 2017 Jun; 69(6):734-743.
Score: 0.024
-
Safety and Clinical Outcomes of Catheter Ablation of Atrial Fibrillation in Patients With Chronic Kidney Disease. J Cardiovasc Electrophysiol. 2017 01; 28(1):39-48.
Score: 0.024
-
Antihypertensive Medication Use in Older Patients Transitioning from Chronic Kidney Disease to End-Stage Renal Disease on Dialysis. Clin J Am Soc Nephrol. 2016 08 08; 11(8):1401-1412.
Score: 0.023
-
Prognostic stratification in older adults commencing dialysis. J Gerontol A Biol Sci Med Sci. 2014 Aug; 69(8):1033-9.
Score: 0.020
-
Variation in initial kidney replacement therapy for end-stage renal disease due to lupus nephritis in the United States. Arthritis Care Res (Hoboken). 2011 Dec; 63(12):1642-53.
Score: 0.017
-
Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum. 2011 Jun; 63(6):1681-8.
Score: 0.016